Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American Trypanosomiasis

Pharmacology

Volumn 76, Issue 3, 2006, Pages 123-128

  González, Patricia ^a   Marín, Clotilde ^a   Rodríguez González, Isabel ^a   Illana, Antonio ^a   Mateo, Hector ^a   Longoni, Silvia Stefánia ^a   Rosales, María Jose ^a   González Coloma, Azucena ^b   Reina, Matías ^c   Sánchez Moreno, Manuel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b INSTITUTO DE CIENCIAS AGRARIAS   (Spain)

^c INSTITUTO DE PRODUCTOS NATURALES Y AGROBIOLOGÍA   (Spain)

Author keywords

Chemotherapy; Diterpenoid alkaloids; Trypanosoma cruzi

Indexed keywords

13 OXOCARDIOPETAMINE; 15,22 O DIACETYL 19 OXODIHYDROATISINE; ANTITRYPANOSOMAL AGENT; ATISINIUM CHLORIDE; AZITINE; BENZNIDAZOLE; DITERPENOID; ISOAZITINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CHAGAS DISEASE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; EPIMASTIGOTE; HOST CELL; IN VITRO STUDY; MAMMAL CELL; MICROBIAL GROWTH; NONHUMAN; PARASITE CULTIVATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE;

ALKALOIDS; ANIMALS; CERCOPITHECUS AETHIOPS; CHAGAS DISEASE; DITERPENES; INHIBITORY CONCENTRATION 50; NITROIMIDAZOLES; PARASITIC SENSITIVITY TESTS; PLANT PREPARATIONS; TIME FACTORS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; VERO CELLS;

EID: 33344458851     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090600     Document Type: Article

References (14)

1. World Health Organization: Eleventh Programme Report of the UNPD/World Bank/Who Special Program for Research and Training in Tropical Diseases (TDR). Geneva, WHO 1993, pp 67-75.
2. Croft SL, Urbina JA, Brun R: Chemotherapy of human leishmaniasis and trypanosomiasis; in Hide G, Mottram JC, Coombs GH, Holmes PH (eds): Trypanosomiasis and Leishmaniasis Biology and Control. Wallingford, Cab International, 1997, pp 245-257.
3. Kirshhoff LV: American Trypanosomiasis (Chagas' disease) and African trypanosomiasis (sleeping sickness). Curr Opin Infect Dis 1994; 7:542-546.
4. Kayser O, Kiderlen AF, Croft SL: Natural products as antiparasitic drugs. Parasitol Res 2003;90(suppl 2):S55-S62.
5. Atta-ur-Rahman, Choudhary MI: Diterpenoid and steroidal alkaloids. Nat Prod Rep 1999;16: 619-635.
6. Panter KE, Manners GD, Steigelmeier BL: Larkspur poisoning: toxicology and alkaloid structure-activity relationships. Biochem Syst Ecol 2002;30:113-128.
7. 3H]noradrenaline uptake of the Aconitum alkaloids aconitine, 3-acetylaconitine, lappaconitine, and N-desacetyllappaconitine in rat hippocampus. Biochem Pharmacol 1998;55: 883-888.
8. González Bessonova IA, Shaidkhodzaeva SA: Hetisane-type diterpene alkaloids. Chem Nat Comp 2000;36:419-477.
9. González-Coloma A, Reina M, Medinaveitia A, Guadaño A, Santana O, Martínez-Díaz R, Ruiz-Mesía L, Alva A, Grandez M, Díaz R, Gavín JA, De la Fuente G: Structural diversity and defensive properties of norditerpenoid alkaloids. J Chem Ecol 2004;30:1393-1408.
10. 20 diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. Int J Antimicrobial Agents 2004;25:136-141.
11. 20 diterpene alkaloids. Chem Biodiv 2004;1:1327-1335.
12. Luque F, Fernández-Ramos C, Entrala E, Rosales MJ, Navarro JAR, Romero MA, Salas JM, Sánchez-Moreno M: In vitro evaluation of newly synthesised [1, 2, 4]triazolo[1, 5a]pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli. Comp Biochem Physiol C Toxicol Pharmacol 2000;126:39-44.
13. Osuna A, Adroher FJ, Lupiañez JA: Influence of electrolytes and non-electrolytes on growth and differentiation of Trypanosoma cruzi. Cell Differ Dev 1990;30:89-95.
14. Nakajima-Shimada J, Hirota Y, Auki T: Inhibition of Tripanosoma cruzi growth in mammalian cells by purine and pirimidine analogs. Antimicrob Agents Chemother 1996;40:2455-2458.